Project Description
Hyperbaric Oxygen Therapy for Diabetes
Diabetes effects more than 12 million people and is the seventh leading cause of death in the U.S. With diabetes primarily affecting the small blood vessels, hyperbaric oxygen therapy (HBOT) has been demonstrated to stimulate angiogenesis compromised blood flow and prevent oxygen failure. Research has shown that HBOT can lower blood sugar levels by increasing cellular sensitivity to insulin and skeletal muscle reception of glucose. Furthermore, recents reports have provided evidence towards linking HBOT to regenerating pancreatic islets of Langerhans, thus potentially producing more insulin. HBOT is often beneficial in treating osteomyelitis and cellulitis, in addition to preventing systemic toxicity and permanent disability. With chronic diabetes, impaired circulation reduces wound healing capability and promotes ulcerations. HBOT increases the amount of oxygen available to ulcerated areas, leading to increased fibroblast activation. Studies have demonstrated the benefits of HBOT for diabetes with the following:
Improves Blood Chemistry Profile
- Fasting Blood Sugar
- Hemoglobin HbA1C
- Lipid Profiles
Advance Glycemic Control
- Increases Pancreatic Islets of Langerhans
- Improves Insulin Sensitivity
- Increases Skeletal Muscle Reception of Glucase
Decreases Cardiovascular Risk
- Promotes Long-Term Blood Pressure Control
- Attenuates Metabolic Syndrome
- Reduces Risk of Sudden Heart Attack Due to Ventricular Arrhythmias
Stimulates Angiogenesis & Reduces Inflammation
- Improves Brain Function & Reduces Risk of Stroke
- Enhances Heart Function & Reduces Risk of Heart Attack
- Reduces Risk of Diabetic Retinopathy
- Decreases Risk of Diabetic Neuropathy
- Minimizes Risk of Diabetic Nephropathy
- Combats Cellulitis
Enhances Internal/External Healing
- Proliferates Epithelialization
- Promotes Closure of Non-Healing Wounds
- Decreases Risk of Infection
- Ameliorates Ulcerations
- Reduces Risk of Amputation
- Remediates Osteomyelitis